Following three successful open calls, EHDEN launches the 4th and final open call for SMEs to apply for training and certification on converting health data from various formats to the OMOP common data model. Today, in Europe, we are challenged to generate insights and evidence from real world clinical data at scale, to support patients, … Read more
When the EU’s Innovative Medicines Initiative launched the five-year EHDEN project in November 2018, it did so with an overarching goal in mind: to significantly improve patient treatment and care by unlocking the under-utilised and transformational potential of real world data. To this end, EHDEN began its journey to provide a new paradigm for the … Read more
Following two successful open calls, EHDEN launches the 3rd open call for SMEs to apply for training and certification on converting health data from various formats to the OMOP common data model. Today, in Europe, we are challenged to generate insights and evidence from real world clinical data at scale, to support patients, clinicians, payers, … Read more
25th January, Brussels, Belgium. EHDEN is delighted that our colleagues in WP2, led by our Partner the National Institute for Health & Clinical Excellence (NICE), have published in PharmacoEconomics in December 2020. Entitled, ‘Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment’, the authors explore the applicability of the OMOP CDM to HTA … Read more
Last week, September 22-23, we had a second training and certification meeting for the SMEs that were selected in our Second open call for SMEs. During these 2 days, another 5 SMEs were certified by EHDEN for their knowledge on standardising health data to the OMOP common data model and the installation of the technical … Read more
22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more
EHDEN has a dedicated work package (WP) focusing on the outreach and the sustainability of the project as it is today and beyond the 5-year timeframe of the project. In this article, WP6 Leads, Johann Proeve and Carlos Diaz zoom in on the work done so far in these two important workstreams. To guide … Read more
15 June, 2020, Brussels, Belgium: From 16 April – 14 May, EHDEN announced a rolling COVID-19 Rapid Collaboration Call. Its goal is to help clinicians, scientists, governments and the public to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. Upon conclusion of … Read more
19 May, 2020, Brussels, Belgium: Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. To help provide these answers, EHDEN announced a rolling COVID-19 Rapid Collaboration Call, which ran from 16 April – 14 … Read more
The ambitions of the EHDEN project are high. We aim to standardise more than 100 million patient records across Europe from different geographic areas and different data sources over the coming five years. Mapping of healthcare data to the OMOP-CDM will facilitate the re-use for a variety of purposes, enhancing and accelerating research and healthcare decision-making for … Read more